Novel Variance-Component TWAS Method for Studying Complex Human Diseases with Applications to Alzheimer's Dementia

Overview

Journal PLoS Genet

Specialty Genetics

Date 2021 Apr 2

PMID 33798195

Citations 28

Authors

Shizhen Tang

Aron S Buchman

Philip L De Jager

David A Bennett

Michael P Epstein

Jingjing Yang

Affiliations

Soon will be listed here.

Abstract

Transcriptome-wide association studies (TWAS) have been widely used to integrate transcriptomic and genetic data to study complex human diseases. Within a test dataset lacking transcriptomic data, traditional two-stage TWAS methods first impute gene expression by creating a weighted sum that aggregates SNPs with their corresponding cis-eQTL effects on reference transcriptome. Traditional TWAS methods then employ a linear regression model to assess the association between imputed gene expression and test phenotype, thereby assuming the effect of a cis-eQTL SNP on test phenotype is a linear function of the eQTL's estimated effect on reference transcriptome. To increase TWAS robustness to this assumption, we propose a novel Variance-Component TWAS procedure (VC-TWAS) that assumes the effects of cis-eQTL SNPs on phenotype are random (with variance proportional to corresponding reference cis-eQTL effects) rather than fixed. VC-TWAS is applicable to both continuous and dichotomous phenotypes, as well as individual-level and summary-level GWAS data. Using simulated data, we show VC-TWAS is more powerful than traditional TWAS methods based on a two-stage Burden test, especially when eQTL genetic effects on test phenotype are no longer a linear function of their eQTL genetic effects on reference transcriptome. We further applied VC-TWAS to both individual-level (N = ~3.4K) and summary-level (N = ~54K) GWAS data to study Alzheimer's dementia (AD). With the individual-level data, we detected 13 significant risk genes including 6 known GWAS risk genes such as TOMM40 that were missed by traditional TWAS methods. With the summary-level data, we detected 57 significant risk genes considering only cis-SNPs and 71 significant genes considering both cis- and trans- SNPs, which also validated our findings with the individual-level GWAS data. Our VC-TWAS method is implemented in the TIGAR tool for public use.

Citing Articles

An Update on Neuroaging on Earth and in Spaceflight.

Kuznetsov N, Statsenko Y, Ljubisavljevic M Int J Mol Sci. 2025; 26(4).

PMID: 40004201 PMC: 11855577. DOI: 10.3390/ijms26041738.

Enhancing disease risk gene discovery by integrating transcription factor-linked trans-variants into transcriptome-wide association analyses.

He J, Perera D, Wen W, Ping J, Li Q, Lyu L Nucleic Acids Res. 2024; 53(1).

PMID: 39535029 PMC: 11724290. DOI: 10.1093/nar/gkae1035.

Multiome-wide Association Studies: Novel Approaches for Understanding Diseases.

Shao M, Chen K, Zhang S, Tian M, Shen Y, Cao C Genomics Proteomics Bioinformatics. 2024; 22(5).

PMID: 39471467 PMC: 11630051. DOI: 10.1093/gpbjnl/qzae077.

Leveraging Random Effects in Cistrome-Wide Association Studies for Decoding the Genetic Determinants of Prostate Cancer.

Shao M, Tian M, Chen K, Jiang H, Zhang S, Li Z Adv Sci (Weinh). 2024; 11(36):e2400815.

PMID: 39099406 PMC: 11423091. DOI: 10.1002/advs.202400815.

Omnibus proteome-wide association study identifies 43 risk genes for Alzheimer disease dementia.

Hu T, Parrish R, Dai Q, Buchman A, Tasaki S, Bennett D Am J Hum Genet. 2024; 111(9):1848-1863.

PMID: 39079537 PMC: 11393696. DOI: 10.1016/j.ajhg.2024.07.001.

References

Cannon M, Mohlke K . Deciphering the Emerging Complexities of Molecular Mechanisms at GWAS Loci. Am J Hum Genet. 2018; 103(5):637-653. PMC: 6218604. DOI: 10.1016/j.ajhg.2018.10.001. View

Albers M, Gilmore G, Kaye J, Murphy C, Wingfield A, Bennett D . At the interface of sensory and motor dysfunctions and Alzheimer's disease. Alzheimers Dement. 2014; 11(1):70-98. PMC: 4287457. DOI: 10.1016/j.jalz.2014.04.514. View

Zhu Z, Zheng Z, Zhang F, Wu Y, Trzaskowski M, Maier R . Causal associations between risk factors and common diseases inferred from GWAS summary data. Nat Commun. 2018; 9(1):224. PMC: 5768719. DOI: 10.1038/s41467-017-02317-2. View

Sun D, Yu Z, Fang X, Liu M, Pu Y, Shao Q . LncRNA GAS5 inhibits microglial M2 polarization and exacerbates demyelination. EMBO Rep. 2017; 18(10):1801-1816. PMC: 5623836. DOI: 10.15252/embr.201643668. View

Tripathi S, Christie K, Balakrishnan R, Huntley R, Hill D, Thommesen L . Gene Ontology annotation of sequence-specific DNA binding transcription factors: setting the stage for a large-scale curation effort. Database (Oxford). 2013; 2013:bat062. PMC: 3753819. DOI: 10.1093/database/bat062. View

Jansen I, Savage J, Watanabe K, Bryois J, Williams D, Steinberg S . Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk. Nat Genet. 2019; 51(3):404-413. PMC: 6836675. DOI: 10.1038/s41588-018-0311-9. View

Nicolae D, Gamazon E, Zhang W, Duan S, Dolan M, Cox N . Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet. 2010; 6(4):e1000888. PMC: 2848547. DOI: 10.1371/journal.pgen.1000888. View

Yang Y, Shi X, Jiao Y, Huang J, Chen M, Zhou X . CoMM-S2: a collaborative mixed model using summary statistics in transcriptome-wide association studies. Bioinformatics. 2019; 36(7):2009-2016. DOI: 10.1093/bioinformatics/btz880. View

Ng B, White C, Klein H, Sieberts S, McCabe C, Patrick E . An xQTL map integrates the genetic architecture of the human brain's transcriptome and epigenome. Nat Neurosci. 2017; 20(10):1418-1426. PMC: 5785926. DOI: 10.1038/nn.4632. View

10.

Reinikainen K, Riekkinen P, Halonen T, Laakso M . Decreased muscarinic receptor binding in cerebral cortex and hippocampus in Alzheimer's disease. Life Sci. 1987; 41(4):453-61. DOI: 10.1016/0024-3205(87)90221-9. View

11.

Zeng P, Zhou X . Non-parametric genetic prediction of complex traits with latent Dirichlet process regression models. Nat Commun. 2017; 8(1):456. PMC: 5587666. DOI: 10.1038/s41467-017-00470-2. View

12.

Saha P, Sen N . Tauopathy: A common mechanism for neurodegeneration and brain aging. Mech Ageing Dev. 2019; 178:72-79. PMC: 6377302. DOI: 10.1016/j.mad.2019.01.007. View

13.

Lambert J, Ibrahim-Verbaas C, Harold D, Naj A, Sims R, Bellenguez C . Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013; 45(12):1452-8. PMC: 3896259. DOI: 10.1038/ng.2802. View

14.

Gusev A, Ko A, Shi H, Bhatia G, Chung W, Penninx B . Integrative approaches for large-scale transcriptome-wide association studies. Nat Genet. 2016; 48(3):245-52. PMC: 4767558. DOI: 10.1038/ng.3506. View

15.

Lee S, Teslovich T, Boehnke M, Lin X . General framework for meta-analysis of rare variants in sequencing association studies. Am J Hum Genet. 2013; 93(1):42-53. PMC: 3710762. DOI: 10.1016/j.ajhg.2013.05.010. View

16.

Chen H, Wang C, Conomos M, Stilp A, Li Z, Sofer T . Control for Population Structure and Relatedness for Binary Traits in Genetic Association Studies via Logistic Mixed Models. Am J Hum Genet. 2016; 98(4):653-66. PMC: 4833218. DOI: 10.1016/j.ajhg.2016.02.012. View

17.

Wostyn P, Audenaert K, De Deyn P . Choroidal Proteins Involved in Cerebrospinal Fluid Production may be Potential Drug Targets for Alzheimer's Disease Therapy. Perspect Medicin Chem. 2011; 5:11-7. PMC: 3072647. DOI: 10.4137/PMC.S6509. View

18.

Babenko V, Smagin D, Galyamina A, Kovalenko I, Kudryavtseva N . Altered Slc25 family gene expression as markers of mitochondrial dysfunction in brain regions under experimental mixed anxiety/depression-like disorder. BMC Neurosci. 2018; 19(1):79. PMC: 6288882. DOI: 10.1186/s12868-018-0480-6. View

19.

Yuan Z, Zhu H, Zeng P, Yang S, Sun S, Yang C . Testing and controlling for horizontal pleiotropy with probabilistic Mendelian randomization in transcriptome-wide association studies. Nat Commun. 2020; 11(1):3861. PMC: 7395774. DOI: 10.1038/s41467-020-17668-6. View

20.

Sheffield L, Miskiewicz H, Tannenbaum L, Mirra S . Nuclear pore complex proteins in Alzheimer disease. J Neuropathol Exp Neurol. 2006; 65(1):45-54. DOI: 10.1097/01.jnen.0000195939.40410.08. View